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Traditional clinical follow-up after breast cancer is inefficient at detecting relapse and is poorly suited to detecting and ameliorating
psychological problems. There is interest in developing more effective and efficient methods of follow-up. We report
a prospective cohort study of the acceptability and feasibility of remote, automated telephone follow-up after breast cancer.
Women with a history of breast cancer were approached at their annual follow-up visit. For participants, the follow-up questionnaire
was administered on paper at baseline. In place of a clinic visit following year, the women completed the same questionnaire using an
automated telephone system. All patients were given mammograms. A semi-structured interview was then conducted to assess the
acceptability. The potential impact on clinic usage was assessed. In all, 110 of 121 women (91%) agreed to participate. Seventy-five
patients (71%) completed follow-up using the new automated system 1 year later. Seventy-one of the 75 patients found the system
easy to use. Forty-nine of the 75 (65.33%) liked the system and were happy to use it as their sole method of follow-up. A further 12%
were happy to use it as part of their follow-up. In only 10.66% of participants were concerns raised which led to clinic attendance.
Automated questionnaire-based telephone follow-up is acceptable to women and has the potential to reduce attendance at clinic.
Further studies to validate this method further are planned.
British Journal of Cancer (2008) 99, 704–710. doi:10.1038/sj.bjc.6604567 www.bjcancer.com
& 2008 Cancer Research UK
Keywords: breast cancer; follow-up; telephone; automated
                                               
The National Institute for Clinical Excellence (NICE) recommend
only 2–3 years of follow-up after treatment for breast cancer
before discharge to the general practitioner (GP) (National
Institute for Clinical Excellence, 2002). There is reluctance on the
part of hospital clinicians to implement these guidelines (Donnelly
et al, 2007). Although breast surgeons and oncologists recognise
the benefit of reduced clinic workload which comes with
discharging patients to general practice, anxiety over perceived
lack of GP training and experience in oncology and potential loss
of patient outcome data leave them reluctant to follow NICE
guidance (Donnelly et al, 2007).
National Institute for Clinical Excellence considers that routine
follow-up should be provided for the detection of locoregional
relapse, provision of psychosocial support and the detection and
amelioration of side effects of therapy (National Institute for
Clinical Excellence, 2002). Routine clinical examination is an
inefficient way of detecting potentially treatable relapse after breast
cancer (de Bock et al, 2004). Local control after breast-conserving
surgery and modern radiotherapy are excellent; event rates are
low. Locoregional relapse, including new contralateral cancers,
occurs with a rate of 1–1.5% of patients at risk per year in a
contemporary cohort, with only 13% of such relapses detected by
routine clinical examination in asymptomatic patients (Montgomery
et al, 2007b). It is possible that this first NICE aim, of detecting
locoregional relapse, may be adequately achieved by regular
mammography and patient education on self-examination in our
patient group (Montgomery et al, 2007b), although this will be
confirmed in future trials.
Routine clinical follow-up appears to have little impact in terms
of the additional aims as outlined by NICE. A recent review
confirmed that the few randomised trials of alternative methods of
follow-up in breast cancer that have been conducted have revealed
no difference in quality of life in patients followed up in the
traditional outpatient setting compared with any alternative
(Montgomery et al, 2007a).
Follow-up by telephone has been tried in other disciplines.
James et al (1994) reported good outcomes in terms of detecting
medical problems and providing support to oncology patients
using a nurse-led telephone system. Automated telephone follow-
up has potential benefits in terms of reducing clinic visits,
reducing workload for clinical staff and improving detection of
psychological problems in women after breast cancer. Such follow-
up could be used as a screening tool for detecting women with
psychosocial problems or side effects of therapy after treatment
for breast cancer, and clinic visits could then be targeted to those
who require such visits. The automation could prove cost effective
in reducing staff requirements. A systematic review of uses of
automated telephone computer systems concluded that the
reliability and availability of such systems made them attractive Received 17 April 2008; revised 6 July 2008; accepted 23 July 2008
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sfor use in follow-up, but that little evidence for their use in this
setting existed and that further trials were needed (Biem et al,
2003).
It is possible that routine clinical examination is unnecessary
after breast cancer and that the first aim of NICE, the detection
of treatable relapse, can be achieved by regular self-examination
and annual mammograms. The intention of this study is to
assess whether a new automated questionnaire-based telephone
follow-up system is an acceptable and feasible method for
achieving the additional aims of the NICE guidelines, those of
detection of side effects and psychological problems.
METHODS
Study design
A prospective cohort study of the acceptability and feasibility of
remote automated questionnaire-based telephone follow-up after
breast cancer.
Inclusion and exclusion criteria All patients with a history of
breast cancer treated with curative intent who had completed their
adjuvant chemo-radiotherapy and who attended a routine follow-
up clinic between 1 May 2006 and 31 August 2006 were asked to
participate.
The following exclusion criteria were applied:
  The presence of local or distant disease at time of clinic.
(Successfully treated previous locoregional relapse was not an
exclusion criterion).
  Inability to complete the questionnaire on paper independently.
  No access to a telephone.
  Inability to consent to participation.
Inability to complete the questionnaire by phone because of
physical difficulties was not an exclusion criterion if a paper
version could be completed and the patient had assistance from a
willing family member to complete the questionnaire over the
phone.
Design of the telephone system An electronic case record
(Excelicaret) with linked telephone system (Excelicare Direct) is
available from AxSys Technology, Glasgow, UK. Questionnaire
scripts can be programmed onto the system, so that patients can
telephone in and complete the questionnaire using an ordinary
touch tone telephone. The answers generated are recorded within
an individual patient record. The system can be programmed to
calculate scores according to the answers given in the ques-
tionnaire and undertake specific actions in the event of certain
answers being given or scores being achieved. For example, an
acceptable score can result in a reassuring letter being generated
by the system and a request for a routine mammogram being sent
to radiology. Poor scores or deterioration from the last-recorded
score can result in an email being sent to a designated person to
ensure that the low score is followed up.
The questionnaire used in this project consisted of two parts. An
initial seven questions were designed to encourage self-examina-
tion and allow the reporting of symptoms that may be associated
with relapse, either locoregional or metastatic. This part of the
questionnaire had not previously been validated and is reproduced
as Appendix 1.
The main objectives of this computer telephone follow-up
system are to improve the detection of psychosocial concerns and
of treatment-related side effects among our patients. The more
general quality of life questionnaires that exist have been shown
to be nonspecific in relation to breast cancer and often insensitive
to problems in breast cancer patients (Hall et al, 1999). For this
reason, the more breast cancer-specific Functional Assessment of
Cancer Therapy-Breast (FACT-B) questionnaire with endocrine
and arm subscales was used here. The characteristics of the
FACT-B questionnaire has been described elsewhere (Brady et al,
1997; Fallowfield et al, 1999; Coster et al, 2001). Briefly, FACT-B is
a 44-item self-report questionnaire designed to measure general
quality of life issues as well as more specific issues related to breast
cancer, and it has been extensively used in both research
and clinical practice. The arm subscale consists of four additional
items used in conjunction with FACT-B and has been shown to
be sensitive to deterioration in arm function associated with the
development of lymphoedema, as well as being sensitive to
improvement in function associated with effective treatment
(Coster et al, 2001). The endocrine subscale consists of 18 items
designed to detect endocrine symptoms related to adjuvant
treatment (Fallowfield et al, 1999). The full FACT-B questionnaire
with arm and endocrine subscales is reproduced as Appendix 2.
Protocol Follow-up is conducted on an annual basis within our
unit. At the end of a routine scheduled clinic visit, patients were
invited to complete their next follow-up visit the following year
using the computer telephone system.
Patients who agreed to participate completed the full ques-
tionnaire on paper before leaving the clinic to obtain a baseline
score. They were informed that they would be written to 10 months
later and asked to complete the same questionnaire over the
telephone. The automated nature of the system was explained to
them in detail. All participants were informed that they could
withdraw consent and come for a standard clinic visit at any time,
and were informed that this author (DAM) would telephone them
after they had completed the telephone follow-up questionnaire to
go over their answers with them, address any concerns they had
and obtain feedback on the system.
Ten months after recruitment, all participants were written to
with instructions to telephone in and complete the questionnaire.
Full instructions on how to use the telephone system are included
on the system and were backed up by written instructions on the
letter. A paper version of the complete questionnaire was sent to all
participants so that they could go over their answers beforehand if
they wished.
All patients were telephoned by the author within 1 week of
completing the telephone-based questionnaire. A semi-structured
interview was conducted; the questions used are reproduced as
Appendix 3. Any areas of low score or significant deterioration
from the baseline score in any part of the questionnaire were
discussed. Previous studies have suggested that the minimally
important change in score in any section of the FACT-B
questionnaire, which is associated with a true deterioration in
symptoms important to the patient, is 5% of the total available
score for that section (Cella et al, 2002; Eton et al, 2004). This was
taken to be the case for this initial study. If the patient answered
yes to any of the initial seven questions, this was also discussed.
Problems that could not be resolved over the telephone resulted in
an appointment being sent for the patient to come to the clinic.
Patients were also brought back to clinic if they requested to come
for clinical examination. Finally, all patients were sent appoint-
ments to attend for mammography.
RESULTS
In all, 110 of 121 patients (91%) invited to participate agreed and
completed a baseline questionnaire. The mean age of participants
was 62 years (s.d. 11.8 years), with those refusing to participate
having a mean age of 68 years (s.d. 7.4 years), (P¼NS). The
characteristics of the included patients are shown in Table 1. One
patient, not included in the table, had a single scalp lesion resected,
which was pathologically an oestrogen receptor-positive breast
cancer. Following treatment, she has now been disease-free for
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s5 years in routine follow-up and was keen to give feedback on the
new telephone system.
Nine months after enrolment, all 110 patients who agreed to
participate were cross-referenced with our recurrence database.
Five patients had died since enrolment. The remaining patients
were written to with instructions to telephone in and complete a
follow-up questionnaire over the telephone. Non-responders were
written to once more and then finally telephoned to establish
reasons for non-response and to offer a standard clinic visit.
Willingness to participate Of the 105 patients written to,
75 patients (71%) telephoned in and completed a follow-up
questionnaire. Of the patients who did not complete the
questionnaire over the telephone, three (3%) were uncontactable
by letter or telephone and five (5%) did not complete the
questionnaire even after telephone reminder to do so but gave
no reason for non-participation. Eight (8%) could not manage to
use the telephone system for technical reasons, such as feeling ‘too
old’, deteriorating hearing or intercurrent illness. One patient
claimed that she did not have the time, one felt that it was too
detailed and one patient stated that she did not want to think about
her breast cancer in such detail. Only three patients (3%) did not
want to complete the questionnaire because they preferred to come
to clinic for examination.
The mean age of patients who completed the follow-up
questionnaire using the computer telephone system was 59 years
(s.d. 11 years) compared with a mean age of 67 years (s.d. 11 years)
in those who did not (P¼0.002). In all, 66.66% of women born
between 1930 and 1939 successfully completed the telephone
version, with only 30% of patients born between 1920 and 1929
doing so (w
2 1, d.f. P¼0.046).
Ease of use and acceptability of the telephone system Seventy-one
of the 75 patients who completed the questionnaire found the
computer telephone system easy to use. Two patients were anxious
about using this technology, so completed the questionnaire on
paper and had a member of their family call in the results. All
patients stated that having the questionnaire on paper in front of
them when using the computer telephone service reduced the
anxiety associated with this new technology and simplified the
process.
Forty-nine of the 75 patients (65.33%) who completed the
computer telephone follow-up questionnaire liked the system
and were happy to use it instead of routine clinic visits as their
method of follow-up. Nine patients (12%) liked many aspects
of the computer telephone system and stated that they would be
happy to use it as a component of their follow-up. All nine
of these patients stated that they appreciated the reassurance
of regular clinical examination in addition. Suggestions from
this group for the use of this new system included completing
the questionnaire using the phone system before they came
to clinic in order that their clinic visit could be more focussed
or alternating between telephone follow-up and clinic visits
each year to reduce the frequency of clinic visits. One patient
suggested coupling this new system with clinical examination
by GP.
Patients cited several benefits of this new follow-up method. In
particular, time saved by the patient and the patients’ families was
considered beneficial. One patient stated that she was able to
complete the questionnaire with her daughter and have her
daughter call it in during the evening, thus saving her daughter
from taking a day off work. She additionally stated that coming to
the hospital and trying to find a parking space added greatly to the
stress of an already stressful visit, a concern mirrored by several
others. Several patients stated that not having to take time off work
themselves was of benefit to them.
Table 1 Study population
Age (years)
Mean 62
s.d. 11.8
Range 35–87
Tumour grade No. of patients
DCIS 2
High-grade phylloides 3
12 1
23 8
34 0
Unknown 5
Node status No. of patients
Positive 40
Negative 62
Unknown 7
Procedure No. of patients
Conservation surgery 63
Mastectomy 31
Mastectomy/reconstruction 11
Bilateral procedures 4
Adjuvant hormonal therapy No. of patients
Never 37
Previously 33
Current 37
Stopped between paper and phone versions 3
Time in follow-up Time (years)
Median 5.16
Range 1–20
Age is the age of the patient at the time of recruitment to this study, and time in
follow-up is the time from original diagnosis to enrolment in this study. Tumour
grade, nodal status and procedure all describe initial treatment. Ajuvant hormonal
therapy describes whether the patient has never or has previously had hormonal
therapy, was on hormonal therapy throughout the period of this study (current) or
stopped hormonal therapy between enrolment and at the end of this study.
Table 2 Change in scores between the baseline paper version and the telephone questionnaire completed at 10 months
PWB SWB EWB FWB BCS ESS ARM FACT-B FACT-G FACT-ES
Improved score 21 11 20 12 18 14 18 7 9 7
Static score 42 36 26 33 20 33 36 44 42 38
Deteriorating score 11 27 29 30 35 16 19 21 22 16
Not available
a 1100 2 1 2 2 3 2 1 4
ARM¼arm subscale (5 items); BCS¼breast cancer subscale (9 items); ESS¼endocrine subscale (18 items); EWB¼emotional well being (6 items); FACT-B¼sum of PWB,
SWB, EWB, FWB, BCS; FACT-ES¼sum of PWB, SWB, EWB, FWB, BCS, ESS; FACT-G¼sum of PWB, SWB, EWB, FWB; FWB¼functional well being (7 items);
PWB¼physical well being (7 items); SWB¼social well being (7 items). Scores were considered static if the telephone score was within 5% of baseline score.
aSeveral patients
did not complete all sections of both the baseline and telephone questionnaires and so a difference between the scores was not calculable.
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follow-up method much less stressful than coming to clinic. They
were able to complete the questions in their home environment,
which they found less threatening and less likely to drag up
memories of their treatment. Consequently, they felt more able to
think about how they were feeling in detail, particularly as they
completed the paper version of the questionnaire over a longer
period of time than they usually got to see their doctor in clinic
before phoning in to record their answers on to the computer
system.
A number of patients stated that their communication of
problems within the clinic was limited by feeling embarrassed,
feeling rushed or being so anxious that they forgot to mention
things that had been concerning them. As a result of alleviation of
all these factors, 29 of the 49 patients who were happy to use this as
their sole method of follow-up felt it gave them more opportunity
to divulge problems than was the case in the clinic.
Most patients described the questionnaire as being very detailed.
This allowed them not only to report all the problems that they had
encountered, but several women commented that, as a result of
participating in this study, they felt much more aware of the type
of problems that they may encounter in the future and they were
now more confident that they would notice if something went
wrong.
Twelve patients (16%) stated that they would not be happy to
use this type of follow-up at all. Two had medical problems
ongoing at the time of completion of the telephone questionnaire
and suggested that their anxieties over these problems might have
affected their view of the system. Four had technical problems with
the system or were nervous about the new technology, including
two who completed the questionnaire on paper and got their
daughter to call in. These patients felt less in control than they did
when attending clinic as they had to rely on family members to
convey problems. Interestingly, two patients stated that the
questionnaire had too much detail and they did not want to think
about their breast cancer treatment in the amount of detail
required to complete this type of follow-up. The rest of this group
stated that they would prefer to come to clinic for an examination.
Three patients (4%) were undecided about whether they would
like to use this type of follow-up. Two of these patients were at any
early stage in their follow-up and felt that they would like to keep
coming to clinic for a few more years until things were a bit more
stable. One did not feel that the questionnaire asked the right kind
of questions, but felt that clinic was not of much benefit to her
either. In fact, this patient had a very detailed conversation
regarding her poor scores in a number of areas of the
questionnaire and it is likely that her level of anxiety required
additional input. By the end of the conversation, she did concede
that perhaps longer clinic appointments were needed to discuss
her problems and that it had been the new telephone system that
had uncovered this fact.
Finally, one patient completed the telephone questionnaire after
several attempts to contact her by post and by phone. She was
uncontactable after completing the questionnaire either by post
or by telephone and subsequently did not attend a clinic
appointment.
Detecting problems using computer telephone follow-up The
potential impact of introducing the new computer telephone
follow-up system was assessed by establishing how many patients
would require to be telephoned or brought back to clinic in light of
their scores on the questionnaire. As mentioned above, a change in
score of 5% or more of the total score available for each section is
considered a significant change in score (Cella et al, 2002; Eton
et al, 2004). Patients recording deterioration in score of 5% or
more would be telephoned to discuss this. Patients with issues
unable to be resolved through telephone consultation would be
brought back to clinic for further assessment, investigation or
treatment. Patients answering yes to any of the initial seven
questions outlined in Appendix one, designed to allow the patients
to highlight easily any new problem they had developed in their
breast or arm pit, were also telephoned to discuss the problem that
had led to them answering yes and to arrange for them to be
brought back to clinic if there were problems that required further
investigation. Table 2 outlines the changes in scores for each of the
sections for the 75 patients who completed the follow-up
questionnaire using the phone system.
In total, 66 of the patients (88%) had deterioration in score in at
least one section of the questionnaire of more than 5% of the total
score available for that section. Forty-three patients answered yes
to at least one of the initial questions shown in Appendix 1. Forty
of these had also recorded deterioration in some aspect of their
questionnaire and three had not. Therefore 69 patients (92%)
either answered yes to one of the initial seven questions or had
deterioration in their score from baseline of more than 5% in at
least one section of the questionnaire. All patients were telephoned
to discuss their scores.
The majority of patients stated that they felt no different at the
time of the telephone questionnaire compared to when filling out
the baseline questionnaire (on paper) the year before, or felt that
their change in score was related to other problems in their life. In
particular, a number of patients with arthritis attributed much of
their deterioration in scores to joint pain, which had increased
over the course of the year. One patient had suffered deterioration
in her functional and emotional scores, but had already been
investigated by her GP and was seeing a psychologist. All patients
with deterioration in endocrine scores were given advice on dose
splitting, one was sent to her GP for venlafaxine prescription and
one patient was brought back to clinic to further discuss treatment
options.
Four patients complained of a new bone pain that could not be
dealt with satisfactorily over the telephone and all four of these
patients were brought back to clinic for further treatment or
investigation. One patient had had recent further axillary surgery
for cosmesis and had developed some troublesome lymphoedema.
She was referred to the lymphoedema clinic. Three patients
brought back to investigate new lumps in the breast or axilla (all
were benign) and one patient had been back for investigation of a
new lump 1 week before completing the telephone questionnaire.
One patient had suffered a marked deterioration in endocrine
scores and complained of vaginal bleeding, but had just been
diagnosed with endometrial cancer having been referred to
gynaecology by her GP.
From all 75 patients who responded, only eight (10.66%)
required to be brought back to clinic for further investigation or
treatment of problems raised during the telephone follow-up.
DISCUSSION
Remote automated computer telephone follow-up has potential to
reduce the burden on outpatient clinics by limiting the number of
people who need to attend, while allowing clinicians to stay in
charge of the ongoing management of their patients. The system
allows continued generation of not only outcome data, but far
more data on quality of life and side effects of therapy than would
usually be available for patients out with the setting of a clinical
trial.
This is the first study that we are aware in which specific quality
of life tools have been used as part of the routine follow-up process
in an attempt to more objectively uncover psychosocial concerns
and side effects of treatment. Quality of life tools have been used to
assess the impact of novel follow-up methods previously (Grunfeld
et al, 1996, 2006; Brown et al, 2002; Koinberg et al, 2004), but never
specifically to screen for problems. Using such tools in this way
should be done with care. The FACT-B questionnaire and the
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diagnostic tools in their own right. Yet these questionnaires do
allow a very detailed assessment of patients’ functioning across a
wide spectrum of areas.
There are well-defined criteria as to what is likely to constitute a
significant change in score, usually considered to be a change in
5% or more of the total score available for each section (Cella et al,
2002; Eton et al, 2004), and there is extensive data pertaining to the
use of this questionnaire and the range of scores normally
expected, although much of these data come from clinical trials
and may not reflect the range of scores seen in our population.
It is difficult from this early pilot study to assess how much time
could be saved by this follow-up method. In this study, all patients
were telephoned by a senior doctor after completion of the
questionnaire. This might have influenced their willingness to
participate and their perception of the quality of the follow-up. In
future, this phone call will only happen in the event of the
computer system noting a deteriorating or low score, and then will
be delegated to a senior nurse. It would be important to ensure that
patients still found this acceptable before making definite
predictions of how much resource could be saved.
In this study, most patients required to be telephoned because of
reductions in scores between baseline administration of the
questionnaire on paper and the telephone version completed at
1 year, but few felt that their situation had changed significantly
and only eight patients needed to come up to clinic. Work is
ongoing to assess the correlation between paper and telephone
administration of this questionnaire. These two methods of
administration are very different. Earlier study has shown that
patients are more honest when reporting symptoms and so on to
an automated computer telephone system than when completing
questionnaires in other ways (Kobak et al, 1997; Turner et al, 1998;
Millard and Carver, 1999). Technical differences between the
two methods, as well as differences in the physical setting where
each questionnaire was completed, may also lead to systematic
difference in score between questionnaires filled out on paper
compared with those by telephone. An option in future would be to
have the baseline questionnaire completed remotely also.
Functional Assessment of Cancer Therapy-Breast was not
developed as a diagnostic tool and so the overall scores and
changes in score for an individual patient must be interpreted with
caution. As mentioned by Cella et al (2002), the derived change in
score in an individual may reflect true change, although the degree
of measurement error in individual assessment precludes the use
of these scores for individual diagnosis. Rather, the scores derived
for any patient can be interpreted in much the same way as any
screening test, as long as one keeps in mind the consequences of
false-positive and false-negative results.
This study reveals automated telephone follow-up to be both
feasible and acceptable to a large proportion of women. The
majority of the women approached to take part in this study were
happy to do so, with a randomisation rate of 91%, although it
will be important to assess again how acceptable this method of
follow-up is when patients are not routinely receiving a follow-up
phone call and when the system is being run by senior nurses
rather than by a doctor as was the case here. There was a drop-out
rate subsequently, with some 30 patients (29% of patients who
agreed to take part) not completing the telephone questionnaire
10–12 months after recruitment and as such it is likely that
traditional clinics will continue for some people, particularly those
aged over 75.
A number of women liked the technology, but were put off by
not seeing a doctor face to face. For these patients, there remains
the option of partnership with general practice whereby their
attendance at clinic could be avoided, but they could still have
some examination in primary care. This both reduces workload at
clinic and has the potential to address GP concerns that they lose
touch with their patient after a diagnosis of breast cancer as their
care is all delivered centrally (Anvik et al, 2006).
Among participants, this novel method of follow-up was
acceptable, with almost 80% agreeing that there were benefits to
this type of follow-up over traditional clinic visits. Most of these
patients felt that the process was more detailed than was usually
the case during routine clinic visits. In this initial feasibility study,
there was no formal assessment of the impact of this system on
quality of life. We would hope this more detailed questioning
would lead to greater detection of problems, a higher level of
input to attempt to resolve these problems and ultimately would
translate to an improved quality of life among participants in
this type of follow-up process. Importantly, this more detailed
questioning places no additional burden on resource when
conducted using the automated phone system as all scores are
calculated and data collated by the computer.
SUMMARY
It is likely that this system will reduce the need for routine clinic
visits, but this will be offset in part by the need for a specialist
nurse to oversee the telephone system, interpret patients’ scores
and telephone those patients who raise concerns with their
telephone follow-up. This is nonetheless a more flexible arrange-
ment than is currently available. With this new system, women can
contact their secondary care team at any time without the need for
clinic space and it is likely that only a small proportion will require
to come to clinic. This should provide increased capacity to help
meet the demand to see new patients quickly, without compromis-
ing the care of our long-term patients, and should ensure that
clinic visits are more focussed on the needs of those attending.
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Appendix 1
Initial seven questions
Appendix 2
FACT-B with arm and endocrine subscales as used in this project
1 How often have you examined your breasts since we last saw you? (please circle one)
not at all, every day, every week, every month, when and if I remember
2 Have you noticed any changes in your breast? Yes No
3 Have you noticed any changes in your operation scar? Yes No
4 Have you noticed any changes in your arm pit? Yes No
5 Have you had any NEW problems with breathlessness Yes No
5 Have you had any NEW problems with persistent cough Yes No
7 Have you developed any NEW aches and pains in your bones recently? Yes No
Physical well-being Not at
all
A little
bit
Some-
what
Quite
a bit
Very
much
GP1 I have a lack of energyyyyyyyyyyyyyyyyyy 01 234
GP2 I have nausea yyyyyyyyyyyyyy.. 0 1 2 3 4
GP3 Because of my physical condition, I have trouble meeting the needs of my
familyyyyyyyyyyyyyyyyy
01 234
GP4 I have painyyyyyyyyyyyyyy.. 0 1 2 3 4
GP5 I am bothered by side effects of the treatmentyyyyyyyyyyyyyyy.. 0 1 2 3 4
GP6 I feel illyyyyyyyyyyyyyyyy.0 1 2 3 4
GP7 I am forced to spend time in bedyyyyyyyyyyyyyyyyyy 01 234
Social/family well-being Not at
all
A little
bit
Some-
what
Quite
a bit
Very
much
GS1 I feel close to my friendsyyyyyyyyyyyyyyyyyyy 01 234
GS2 I get emotional support from my familyyyyyy.. 0 1 2 3 4
GS3 I get support from my friendsyyyyyyyy.. 0 1 2 3 4
GS4 My family has accepted my illnessyyyyyy 01 234
GS5 I am satisfied with family communication about my
illnessyyyyyyyyyyyyyyyyyyy
01 234
GS6 I feel close to my partner (or the person who is my main
support)yyyyyyyyyyyyyyy
01 234
Q1 Regardless of your current level of sexual activity, please answer the following question.
If you prefer not to answer it, please check this box & and go to the next section.
GS7 I am satisfied with my sex lifeyyyyyyyyyyy 01 234
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Questions used for the semi-structured interview after completion
of the telephone follow-up at 1 year:
  Did you find the system easy to use?
  What, if anything, did you like about this type of follow-up,
compared with coming up to the clinic?
  What, if anything, did you not like about this type of follow-up?
  Do you have any ideas regarding how it could be improved?
  Do you feel sufficiently reassured by this type of follow-up?
(Remembering that you would get feedback on how you scored
and will also get a mammogram in the next few weeks.)
  Do you feel that the telephone questionnaire gave you more,
less or just about the same opportunity to tell us about
things that are worrying you compared with coming to
clinic?
  Would you be happy to use this as your only method of
follow-up, along with the mammograms each year?
Appendix 2 (Continued)
Emotional well-being Not at
all
A little
bit
Some-
what
Quite
a bit
Very
much
GE1 I feel sadyyyyyyyyyyyyyyyyyyyy 01 234
GE2 I am satisfied with how I am coping with my illnessyy.yyyyyyyyyyyyyy 01 234
GE3 I am losing hope in the fight against my illnessyy.. 0 1 2 3 4
GE4 I feel nervousyyyyyyyyyyyyyy 01 234
GE5 I worry about dyingyyyyyyyyyyyyy 01 234
GE6 I worry that my condition will get worseyyyyy.0 1 2 3 4
Functional well-being Not at
all
A little
bit
Some-
what
Quite
a bit
Very
much
GF1 I am able to work (include work at home)yyyyy 01 234
GF2 My work (include work at home) is fulfillingyyy.0 1 2 3 4
GF3 I am able to enjoy lifeyyyyyyyyyyyy.0 1 2 3 4
GF4 I have accepted my illnessyyyyyyyyy.0 1 2 3 4
GF5 I am sleeping wellyyyyyyyyy 01 234
GF6 I am enjoying the things I usually do for funyyy.. 0 1 2 3 4
GF7 I am content with the quality of my life right nowy.. 0 1 2 3
Breast cancer subscale Not at
All
A little
bit
Some-
what
Quite
a bit
Very
much
B1 I have been short of breathyyyyyyyyy.0 1 2 3 4
B2 I am self-conscious about the way I dressyyy.. 0 1 2 3 4
B3 One or both of my arms are swollen or tenderyyy 01 234
B4 I feel sexually attractiveyyyyyyyyyyy.. 0 1 2 3 4
B5 I am bothered by hair lossyyyyyyyyyyyyy 01 234
B6 I worry that other members of my family might someday get the same illness I haveyyyyyy 01 234
B7 I worry about the effect of stress on my illnessyy 01 234
B8 I am bothered by a change in weightyyyyyy.0 1 2 3 4
B9 I am able to feel like a womanyyyyyyyy.. 0 1 2 3 4
P2 I have certain parts of my body where I experience significant painyyyyyyyyyyyy.. 0 1 2 3 4
Q6 On which side was your breast operation? Left Right
B10 Movement of my arm on this side is painful .................. 0 1 2 3 4
B11 I have a poor range of arm movements on this side y... 0 1 2 3 4
B12 My arm on this side feels numb yyyyyyyyy.0 1 2 3 4
B13 I have stiffness of my arm on this side .......................y 01 234
Endocrine concerns Not at
all
A little
bit
Some-
what
Quite
a bit
Very
much
ES1 I have hot flashesyyyyyyyyyyyyyy 01 234
ES2 I have cold sweatsyyyyyyyyyyyy.0 1 2 3 4
ES3 I have night sweats yyyyyyyyyyyyy.0 1 2 3 4
ES4 I have vaginal dischargeyyyyyyyyyy.0 1 2 3 4
ES5 I have vaginal itching/irritationyyyyyyyy.0 1 2 3 4
ES6 I have vaginal bleeding or spottingyyyyyyy.. 0 1 2 3 4
ES7 I have vaginal drynessyyyyyyyyyyyy.0 1 2 3 4
ES8 I have pain or discomfort with intercourseyyy 01 234
ES9 I have lost interest in sexyyyyyyyyyyy.0 1 2 3 4
ES10 I have gained weightyyyyyyyyyyyyy 01 234
An9 I feel light-headed (dizzy)yyyyyyyyyy.0 1 2 3 4
O2 I have been vomitingyyyyyyyyyyyy.. 0 1 2 3 4
C5 I have diarrhoeayyyyyyyyyyyyyy.. 0 1 2 3 4
An10 I get headachesyyyyyyyyyyyyyyy 01 234
Tax1 I feel bloatedyyyyyyyyyyyyyyyy 01 234
ES11 I have breast sensitivity/tendernessyyyyyyy.. 0 1 2 3 4
ES12 I have mood swingsyyyyyyyyyyyyy... 0 1 2 3 4
ES13 I am irritableyyyyyyyyyyyyyyy 01 234
BRM 1 I have pain in my joints 01 234
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